Skip to main content
Structure corrector neutralizes protein linked to Alzheimer's disease
4/12/2018

Researchers at Gladstone Institutes reported in the journal Nature Medicine that they were able to neutralize the gene for apolipoprotein E4, associated with a high risk for Alzheimer's disease, and restored normal function to the brain cells. The researchers will now work with the pharmaceutical industry on clinical trials of the structure-correcting compound.

Full Story: